Bromocriptine mesylate tablets are available in bottles containing 30 and 100 tablets of 2
85 hr, respectively
The initial dosage of Parlodel SnapTabs in adults is one ½ to one 2½ mg scored tablet daily
Bromocriptine mesylate should be initiated at one tablet (0
It should not be used to treat type-1 diabetes or diabetic ketoacidosis
85 hr, respectively
The most commonly reported adverse reactions have included nausea, headache, dizziness, vomiting, and fatigue
25–2
For a full list of excipients see section 6
This draft guidance, when finalized, will represent the current thinking of the Food and Drug Administration (FDA, or the Agency) on this topic
Highlights of Bromocriptine Mesylate Tablets contain bromocriptine mesylate (C 32 H 40 BrN 5 O 5 ·CH 4 SO 3) equivalent to NLT 90
Standard solution— Using an accurately weighed quantity of USP Bromocriptine Mesylate RS, prepare a solution in the Solvent solution having a known concentration of about 0
8 mg tablets, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Bromocriptine mesylate is chemically
The dopaminergic neurons in the tuberoinfundibular process modulate the secretion of prolactin from the anterior pituitary by secreting a prolactin inhibitory factor (thought to be dopamine); in the corpus striatum the dopaminergic neurons are involved
of bromocriptine